GenSight Biologics
Clinical-stage biotechnology company developing gene therapies for retinal diseases and central nervous system disorders, with lead product LUMEVOQ for Leber hereditary optic neuropathy.
Location
Paris, France
Founded
2012
Investors
1
Categories
gene-therapy, biotech, ophthalmology, rare-disease
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Abingworth | London, UK / Boston, USA | biotech-focused | seedseries-a+3 | 34 |